In Vitro Dissolution Profile of Dapagliflozin: Development, Method Validation, and Analysis of Commercial Tablets

Dapagliflozin was the first of its class (inhibitors of sodium-glucose cotransporter) to be approved in Europe, USA, and Brazil. As the drug was recently approved, there is the need for research on analytical methods, including dissolution studies for the quality evaluation and assurance of tablets....

Descripción completa

Detalles Bibliográficos
Autores principales: de Meira, Rafaela Zielinski Cavalheiro, Maciel, Aline Biggi, Murakami, Fabio Seigi, de Oliveira, Paulo Renato, Bernardi, Larissa Sakis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554998/
https://www.ncbi.nlm.nih.gov/pubmed/28831283
http://dx.doi.org/10.1155/2017/2951529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554998/
https://www.ncbi.nlm.nih.gov/pubmed/28831283
http://dx.doi.org/10.1155/2017/2951529

Ejemplares similares